Europe
MorphoSys AG announced today that its licensee Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) has announced new data that, according to a press released issued by Janssen on September 12, 2018
Advancing the next generation of batteries
René Hoet brings over 20 years of experience as a leader in antibody discovery and development
Investment in digital healthcare company Rinicare is milestone deal for Fund
Peerwith is pleased to announce a new partnership with the independent academic publisher, De Gruyter, a company with a tradition dating back to 1749.
Galapagos NV announced today the closing of its underwritten public offering of 2,961,373 American Depositary Shares (“ADSs”) at a price of $116.50 per ADS
Galapagos NV announces a share capital increase as a result of a public offering of American Depositary Shares.
LEO Pharma A/S and MorphoSys AG today announced an expansion of their existing strategic alliance to include peptide-derived therapeutics.
Persons with Alzheimer’s disease (AD) are more often hospitalized after antibiotic initiation than people without AD, a new study from the University of Eastern Finland shows.
Neurimmune today announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a collaboration focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases.
PRESS RELEASES